Diametric Capital, LP Astrazeneca PLC Transaction History

Diametric Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $1.47 Million - $1.7 Million	-27,753 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.2 Million - $1.54 Million	27,753 New	27,753 $1.47 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $831,281 - $987,905	-19,578 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $785,469 - $890,211	19,578 New	19,578 $873,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $1.93 Million - $2.16 Million	-51,881 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $478,724 - $580,296	-13,489 Reduced 20.63%	51,881 $2.1 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $550,872 - $620,068	14,945 Added 29.64%	65,370 $2.48 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $1.75 Million - $2 Million	50,425 New	50,425 $2 Million

1,351

489M

5.88M

4.1M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.